Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiers

被引:147
|
作者
Ching, H. L.
Burke, V.
Stuckey, B. G. A. [1 ]
机构
[1] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Keogh Inst Med Res, Nedlands, WA 6009, Australia
[2] Univ Western Australia, Royal Perth Hosp, Res Unit, Sch Med & Pharmacol, Perth, WA 6009, Australia
关键词
SHORT FORM-36 SF-36; QUESTIONNAIRE PCOSQ; ROTTERDAM CRITERIA; ADOLESCENT GIRLS; LASER TREATMENT; HIRSUTE WOMEN; MANAGEMENT; DIAGNOSIS; POPULATION; DISTRESS;
D O I
10.1111/j.1365-2265.2007.02742.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Polycystic ovary syndrome (PCOS) has clinical features and implications for long-term health that may lead to decreased quality of life (QoL) and psychological morbidity. We studied QoL in women with PCOS, compared the findings with population norms and assessed whether they correlated with reported quality of patient information received. Design Cross-sectional study. Patients Women with PCOS by National Institutes of Health (NIH) criteria, diagnosis confirmed by one endocrinologist. Measurements Four questionnaires were mailed: the Short Form-36 (SF-36), the Quality-of-Life Questionnaire for Women with Polycystic Ovary Syndrome (PCOSQ), the General Health Questionnaire-28 (GHQ-28) and an assessment of information quality and sources, the Patient Information Questionnaire (PIQ). Results Questionnaires were sent to 443 women with PCOS from one endocrinologist's database; 203 women aged 15-65 years agreed to participate. To compare with Australian population norms, data from those women aged 18-44 years (n = 173) were used. Of these, 64% were obese, 18% overweight and 18% of normal weight. The demographics, socioeconomic status and untreated biochemistry of the responders and the total patient group were not significantly different. SF-36 scores were significantly lower than the age- and sex-matched Australian population (P < 0.01), including the overweight subset (P < 0.01). Health-related QoL by PCOSQ was similar to other published studies. GHQ-28 identified psychological morbidity in 62.4%, compared with 26.4% in a matched Australian population (P < 0.0001). Body mass index (BMI) was negatively correlated with QoL (P < 0.01). There was a positive association between the psychological domain of QoL and the subjective assessment of the quality of health-related information in general (P < 0.001), for hirsutism (P < 0.01) and for menstrual irregularity (P < 0.05). Conclusions We have shown impaired QoL and increased prevalence of psychological morbidity in PCOS compared with population norms. The perception of inadequate information about the condition correlated with poorer QoL scores. Improved information delivery may lead to an improvement in QoL and needs to be tested with an intervention study.
引用
收藏
页码:373 / 379
页数:7
相关论文
共 50 条
  • [21] The influence of body weight on sexual function and quality of life in women with polycystic ovary syndrome
    Cristina Laguna Benetti-Pinto
    Silvia Regina Ferreira
    Armando Antunes
    Daniela Angerame Yela
    Archives of Gynecology and Obstetrics, 2015, 291 : 451 - 455
  • [22] Effects of androgen excess and body mass index on endothelial function in women with polycystic ovary syndrome
    Berbrier, Danielle E.
    Leone, Cheryl A.
    Adler, Tessa E.
    Bender, Jeffrey R.
    Taylor, Hugh S.
    Stachenfeld, Nina S.
    Usselman, Charlotte W.
    JOURNAL OF APPLIED PHYSIOLOGY, 2023, 134 (04) : 868 - 878
  • [23] Assessment of quality of life among women with polycystic ovary syndrome of different reproductive age
    Pakharenko, L., V
    Vorobii, V. D.
    Kurtash, N. Ya
    Perkhulyn, O. M.
    ZAPOROZHYE MEDICAL JOURNAL, 2019, (01) : 100 - 103
  • [24] Comparison of Central Fat Accumulation Indices with Body Mass Index in Women with Polycystic Ovary Syndrome
    Singh, Neha
    Hooja, Nupur
    JOURNAL OF OBSTETRICS AND GYNECOLOGY OF INDIA, 2023, 73 (SUPPL 1): : 156 - 160
  • [25] A polymorphism in the resistin gene promoter is associated with body mass index in women with polycystic ovary syndrome
    Xita, N
    Georgiou, L
    Tsatsoulis, A
    Kourtis, A
    Kukuvitis, A
    Panidis, D
    FERTILITY AND STERILITY, 2004, 82 (05) : 1466 - 1467
  • [26] Increased epicardial fat thickness is related with body mass index in women with polycystic ovary syndrome
    Soydinc, E.
    Soydinc, S.
    Ariturk, Z.
    Tekbas, E.
    Cakici, M.
    Islamoglu, Y.
    Ercan, S.
    Sari, I.
    Davutoglu, V.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2013, 17 (15) : 2111 - 2113
  • [27] Relationship between body mass index and endothelial dysfunction in women with and without polycystic ovary syndrome
    Adler, Tessa E.
    Usselman, Charlotte W.
    Anaeto, Laura C.
    Schapiro, Rebecca G.
    Steele, Frances E.
    Toffoloni, Nikoletta
    Takamata, Akira
    Taylor, Hugh S.
    Stachenfeld, Nina S.
    FASEB JOURNAL, 2017, 31
  • [28] Association Between Plasma Sclerostin Levels and Body Mass Index in Women With Polycystic Ovary Syndrome
    Bertizlioglu, Mete
    Kebapcilar, Ayse Guel
    Kebapcilar, Levent
    Akyurek, Fikret
    Sert, Zekiye Soykan
    Celik, Cetin
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [29] DYSLIPIDEMIA IN RELATION TO BODY MASS INDEX AND INSULIN RESISTANCE IN CHINESE WOMEN WITH POLYCYSTIC OVARY SYNDROME
    Hong, Y.
    Yang, D.
    Liu, W.
    Zhao, X.
    Chen, X.
    Li, L.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2011, 25 (03): : 365 - 374
  • [30] Comparison of Central Fat Accumulation Indices with Body Mass Index in Women with Polycystic Ovary Syndrome
    Neha Singh
    Nupur Hooja
    The Journal of Obstetrics and Gynecology of India, 2023, 73 (Suppl 1) : 156 - 160